With food shortages coming, it’s a smart move to order organic, cooked, freeze-dried chicken for long-term storage from Prepper Organics.
The U.S. Food and Drug Administration on Tuesday released a 10,000-page cache of documents pertaining to the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID vaccine.
The documents provide more insights into the FDA’s process for approving the vaccine, and may also shed more light on the safety and efficacy of the vaccines and the number and nature of adverse effects that were observed during the clinical trials and the first months after the EUA was issued.
The documents were made public as part of a court-ordered release schedule stemming from an expedited Freedom of Information Act (FOIA) request by Public Health and Medical Professionals for Transparency (PHMPT).
PHMPT, a group of medical and public health professionals and scientists from Harvard, Yale, UCLA and other institutions, submitted the request in August 2021.
The FOIA request asked for the approximately 400,000 pages of documents pertaining to the approval of the Pfizer COVID vaccine to be made public, including safety and effectiveness data, adverse reaction reports and a list of the vaccine’s active and inactive ingredients.
When the FDA ignored the request, PHMPT sued the agency in September 2021, taking the case to the U.S. District Court for the Northern District of Texas. On Feb. 2, federal judge Mark Pittman issued an order requiring the FDA to release redacted versions of the documents in question according to the following disclosure schedule:
- 10,000 pages apiece, due on or before March 1 and April 1, 2022.
- 80,000 pages apiece, to be produced on or before May 2, June 1 and July 1, 2022.
- 70,000 pages to be produced on or before Aug. 1, 2022.
- 55,000 pages per month, on or before the first business day of each month thereafter, until the release of the documents has been completed.
The cache of documents made public on March 1, available on PHMPT’s website, represents the first release of such documents following the issuance of Pittman’s order in February.
However, the FDA released smaller sets of documents in November and December 2021 and January 2022, while the legal case was ongoing.
What do the documents reveal?
The first batch of documents, produced in November 2021 and totaling a mere 500 pages, revealed safety concerns and the fact that more than 1,200 vaccine-related deaths occurred within the first 90 days following the release of the Pfizer-BioNTech COVID vaccine.
The documents also revealed a nine-page list of adverse events observed during that same period. The list recently was circulated widely on social media and wrongly attributed to the set of documents released March 1.
This may be because the March 1 document release garnered widespread attention among those following the issue, likely delivering traffic to PHMPT’s website, which catalogs all of the documents that have been released thus far.
Major media outlets, however, have not covered the latest release of documents and, as of this writing, there has been only limited coverage by smaller media outlets. That may be due, at least in part, to the vast volume of information and data to sort through.
Endpoints News, a publication focusing on the pharmaceutical industry, published a dismissive article regarding the release of the latest cache of documents.
The publication’s editor, Zachary Brennan, reported the documents contain mundane information that is “typical for any drug or vaccine application” and that “will give readers a good overall sense of the required documentation necessary to apply for a drug or vaccine approval at the FDA.”
Such information includes, according to Brennan, “more than 100 pages worth of anonymous safety-related tables of data” and “unidentified participants’ gender, age and BMI.”
Other documentation pertains to “the standard, nearly $2.9 million user fee payment to FDA from Pfizer” and to “the confidential nonclinical overview for the vaccine,” Brennan said.
Brennan noted some documents included in the cache, such as the fast track designation letter and Pfizer’s request for a waiver from adding a suffix to the vaccine’s name, are “not typically released” to the public.
However, aside from this relatively mundane information — whether typically released to the public or not — the latest batch of documents may contain additional revelatory information.
An initial review by The Defender of the information included in this vast set of newly released documents includes:
- Details regarding animal studies that were conducted, and their findings.
- Documents that appear to pertain to specific types of adverse reactions experienced by trial participants, and to COVID-19 infections in trial participants post-vaccination.
- Information about the study protocol, as well as amendments that were made to this protocol.
- Information about Pfizer’s internal review committee for the COVID vaccine.
- The original Pfizer-BioNTech application to market the COVID vaccine, submitted to the U.S. Department of Health and Human Services (HHS).
The sheer volume of information that must be analyzed and processed necessitates careful examination, which will be performed by the editorial staff of The Defender, with further information and any significant revelations to be published in the coming days.
A circuitous legal process and a victory for transparency
The FDA had previously argued it didn’t have enough staff to review, redact and release hundreds of thousands of pages of documents, claiming it could process only 500 pages per month.
This would have meant the cache of documents would not be fully released to the public for approximately 75 years.
This decision was then amended by Pittman’s subsequent Feb. 2 order, truncating the release schedule to a matter of months instead of decades.
Gimmicks work for many precious metals companies. I despise gimmicks, which is why I recommend the straightforward approach of Our Gold Guy. If you want to buy precious metals, don’t get jacked around. Contact Ira.
The Feb. 2 order also granted the FDA the ability to “bank” excess pages as part of this release schedule — meaning that if the agency exceeds its monthly quota in any given month it can apply those extra pages to a subsequent month.
Previously, Pfizer responded to the Jan. 6 order by filing a memorandum with the court requesting to intervene in the case to assist the FDA with the documents’ release, specifically for the “limited purpose of ensuring that information exempt from disclosure under FOIA is adequately protected as FDA complies with this Court’s order.”
Pfizer claimed to support the disclosure of the documents, but asked to intervene in the case to ensure that information legally exempt from disclosure will not be “disclosed inappropriately.”
Pittman rejected Pfizer’s bid in his Feb. 2 order.
In a related matter, Judge Michael Truncale of the U.S. District Court for the Eastern District of Texas on Feb. 10 unsealed 400 pages of documents pertaining to a lawsuit filed by a whistleblower, Brook Jackson.
Jackson formerly worked for Ventavia, a contractor hired by Pfizer to conduct Phase 3 clinical trials of the Pfizer-BioNTech COVID vaccine.
Jackson’s lawsuit alleges multiple improprieties in the clinical trial process during the time that she was employed with Ventavia. The FDA declined to intervene in this case.
Some of the documents pertaining to the approval of the Pfizer-BioNTech COVID vaccine that were released on March 1 appear to directly relate to the clinical trials conducted by Ventavia, and thus may shed light on Jackson’s allegations.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
Will America-First News Outlets Make it to 2023?
Things are looking grim for conservative and populist news sites.
There’s something happening behind the scenes at several popular conservative news outlets. 2021 was bad, but 2022 is proving to be disastrous for news sites that aren’t “playing ball” with the corporate media narrative. It’s being said that advertisers are cracking down, forcing some of the biggest ad networks like Google and Yahoo to pull their inventory from conservative outlets. This has had two major effects. First, it has cooled most conservative outlets from discussing “taboo” topics like Pandemic Panic Theater, voter fraud, or The Great Reset. Second, it has isolated those ad networks that aren’t playing ball.
Certain topics are anathema for most ad networks. Speaking out against vaccines or vaccine mandates is a certain path to being demonetized. Highlighting voter fraud in the 2020 and future elections is another instant advertising death penalty. Throw in truthful stories about climate change hysteria, Critical Race Theory, and the border crisis and it’s easy to understand how difficult it is for America-First news outlets to spread the facts, share conservative opinions, and still pay the bills.
Without naming names, I have been told of several news outlets who have been forced to either consolidate with larger organizations or who have backed down on covering certain topics out of fear of being “canceled” by the ad networks. I get it. This is a business for many of us and it’s not very profitable. Those of us who do this for a living are often barely squeaking by, so loss of additional revenue can often mean being forced to make cuts. That means not being able to cover the topics properly. Its a Catch-22: Tell the truth and lose the money necessary to keep telling the truth, or avoid the truth and make enough money to survive. Those who have chosen survival simply aren’t able to spread the truth properly.
We will never avoid the truth. The Lord will provide if it is His will. Our job is simply to share the facts, spread the Gospel, and educate as many Americans as possible while exposing the forces of evil.
To those who have the means, we ask that you please donate. We have options available now, but there is no telling when those options will cancel us. We have our GivingFuel page. There have been many who have been canceled by PayPal, but for now it’s still an option. Your generosity is what keeps these sites running and allows us to get the truth to the masses. We’ve had great success in growing but we know we can do more with your assistance.
Thank you, and God Bless!